Figure 6 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers

Figure 6 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers

<p>Boxplots showing changes in gene expression from baseline to surgery of the two immune-related signatures (“durvalumab” and “immune-tolerance”) among H-H and H-L Ki67 response categories in the POETIC-treated subset (<b>A</b>) and in the NeoAI study (<b>B</b>). Boxpl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Milana A. Bergamino (15038015) (author)
Beste egile batzuk: Gabriele Morani (15038018) (author), Joel Parker (15038021) (author), Eugene F. Schuster (9726535) (author), Mariana F. Leal (15038024) (author), Elena López-Knowles (15038027) (author), Holly Tovey (9360536) (author), Judith M. Bliss (8827107) (author), John F.R. Robertson (15025368) (author), Ian E. Smith (1545553) (author), Mitch Dowsett (645) (author), Maggie C.U. Cheang (14946768) (author)
Argitaratua: 2025
Gaiak:
Cancer
Tumor Biology
Cancer Detection and Diagnosis
Therapeutic Research and Development
Biomarkers
Genetic biomarkers
Breast Cancer
Drug Resistance
Novel mechanisms
Endocrinology
Translational Research
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak